Biotherapeutics News for August 2010

Biotherapeutics News Archive

CRT and Bayer Schering Pharma to investigate gynaecological and oncological diseases CRT and Bayer Schering Pharma to investigate gynaecological and oncological diseases

Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany, to evaluate new leptin antagonist peptides as potential experimental treatments, initially in the area of gynaecological diseases, including cancer.

Body clock drugs could ease psychiatric disorders Body clock drugs could ease psychiatric disorders

Researchers have used a drug to reset and restart the 24 hour body clock of mice, which could eventually help with human difficulties including some psychiatric disorders, jet lag and the health impacts of shift work.

CRT and ValiRx sign prostate cancer treatment deal CRT and ValiRx sign prostate cancer treatment deal

Cancer Research Technology has signed a deal to provide biotech company ValiRx PLC with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.

Antiviral effective in clinical trial for common cold Antiviral effective in clinical trial for common cold

A pilot clinical trial examining Marinomed’s antiviral nasal spray, which contains carrageenan, has indicated that it is effective as a treatment against the common cold.